Use of Intravitreal Bevacizumab in Eyes With Choroidal Neovascularization Secondary to Angioid Streaks

Sponsor
Asociación para Evitar la Ceguera en México
Study ID
NCT00599820
Phase
PHASE3
Status
Terminated

Conditions

  • Angioid Streaks
  • Choroidal Neovascularization

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

Intravitreal Bevacizumab is an effective treatment for choroidal neovascularization secondary to Angioid Streaks

Key Dates

First listed
Jan 24, 2008
Start date
Nov 30, 2005
Status verified
May 2024
Primary completion
Nov 30, 2005
Completion
May 31, 2006

Study Design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Primary Outcome Measure

BCVA

Related Studies